These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 26581337)

  • 1. Using hiPSCs to model neuropsychiatric copy number variations (CNVs) has potential to reveal underlying disease mechanisms.
    Flaherty EK; Brennand KJ
    Brain Res; 2017 Jan; 1655():283-293. PubMed ID: 26581337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Link between Genetic Disorders and Cellular Impairment, Using Human Induced Pluripotent Stem Cells to Reveal the Functional Consequences of Copy Number Variations in the Central Nervous System-A Close Look at Chromosome 15.
    Casamassa A; Ferrari D; Gelati M; Carella M; Vescovi AL; Rosati J
    Int J Mol Sci; 2020 Mar; 21(5):. PubMed ID: 32182809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unraveling the genetic architecture of copy number variants associated with schizophrenia and other neuropsychiatric disorders.
    Rutkowski TP; Schroeder JP; Gafford GM; Warren ST; Weinshenker D; Caspary T; Mulle JG
    J Neurosci Res; 2017 May; 95(5):1144-1160. PubMed ID: 27859486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Duplication Versus Deletion Through the Lens of 15q13.3: Clinical and Research Implications of Studying Copy Number Variants Associated with Neuropsychiatric Disorders in Induced Pluripotent Stem Cell-Derived Neurons.
    Antony I; Narasimhan M; Shen R; Prakasam R; Kaushik K; Chapman G; Kroll KL
    Stem Cell Rev Rep; 2023 Apr; 19(3):639-650. PubMed ID: 36370261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New considerations for hiPSC-based models of neuropsychiatric disorders.
    Hoffman GE; Schrode N; Flaherty E; Brennand KJ
    Mol Psychiatry; 2019 Jan; 24(1):49-66. PubMed ID: 29483625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Critical reappraisal of mechanistic links of copy number variants to dimensional constructs of neuropsychiatric disorders in mouse models.
    Hiroi N
    Psychiatry Clin Neurosci; 2018 May; 72(5):301-321. PubMed ID: 29369447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Copy number variation and neuropsychiatric illness.
    Rees E; Kirov G
    Curr Opin Genet Dev; 2021 Jun; 68():57-63. PubMed ID: 33752146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Copy number variation at 22q11.2: from rare variants to common mechanisms of developmental neuropsychiatric disorders.
    Hiroi N; Takahashi T; Hishimoto A; Izumi T; Boku S; Hiramoto T
    Mol Psychiatry; 2013 Nov; 18(11):1153-65. PubMed ID: 23917946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of DNA copy number variation in schizophrenia.
    Tam GW; Redon R; Carter NP; Grant SG
    Biol Psychiatry; 2009 Dec; 66(11):1005-12. PubMed ID: 19748074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CNVs: harbingers of a rare variant revolution in psychiatric genetics.
    Malhotra D; Sebat J
    Cell; 2012 Mar; 148(6):1223-41. PubMed ID: 22424231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CRISPR/Cas9-mediated Knockout of the Neuropsychiatric Risk Gene KCTD13 Causes Developmental Deficits in Human Cortical Neurons Derived from Induced Pluripotent Stem Cells.
    Kizner V; Naujock M; Fischer S; Jäger S; Reich S; Schlotthauer I; Zuckschwerdt K; Geiger T; Hildebrandt T; Lawless N; Macartney T; Dorner-Ciossek C; Gillardon F
    Mol Neurobiol; 2020 Feb; 57(2):616-634. PubMed ID: 31402430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sensitivity to gene dosage and gene expression affects genes with copy number variants observed among neuropsychiatric diseases.
    Yamasaki M; Makino T; Khor SS; Toyoda H; Miyagawa T; Liu X; Kuwabara H; Kano Y; Shimada T; Sugiyama T; Nishida H; Sugaya N; Tochigi M; Otowa T; Okazaki Y; Kaiya H; Kawamura Y; Miyashita A; Kuwano R; Kasai K; Tanii H; Sasaki T; Honda M; Tokunaga K
    BMC Med Genomics; 2020 Mar; 13(1):55. PubMed ID: 32223758
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Ishii T; Ishikawa M; Fujimori K; Maeda T; Kushima I; Arioka Y; Mori D; Nakatake Y; Yamagata B; Nio S; Kato TA; Yang N; Wernig M; Kanba S; Mimura M; Ozaki N; Okano H
    eNeuro; 2019; 6(5):. PubMed ID: 31540999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opportunities and limitations for studying neuropsychiatric disorders using patient-derived induced pluripotent stem cells.
    Hong Y; Yang Q; Song H; Ming GL
    Mol Psychiatry; 2023 Apr; 28(4):1430-1439. PubMed ID: 36782062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integration of CRISPR-engineering and hiPSC-based models of psychiatric genomics.
    Matos MR; Ho SM; Schrode N; Brennand KJ
    Mol Cell Neurosci; 2020 Sep; 107():103532. PubMed ID: 32712198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genome arrays for the detection of copy number variations in idiopathic mental retardation, idiopathic generalized epilepsy and neuropsychiatric disorders: lessons for diagnostic workflow and research.
    Hochstenbach R; Buizer-Voskamp JE; Vorstman JA; Ophoff RA
    Cytogenet Genome Res; 2011; 135(3-4):174-202. PubMed ID: 22056632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of copy number variation across the genome with neuropsychiatric traits in the general population.
    Guyatt AL; Stergiakouli E; Martin J; Walters J; O'Donovan M; Owen M; Thapar A; Kirov G; Rodriguez S; Rai D; Zammit S; Gaunt TR
    Am J Med Genet B Neuropsychiatr Genet; 2018 Jul; 177(5):489-502. PubMed ID: 29687944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implications of germline copy-number variations in psychiatric disorders: review of large-scale genetic studies.
    Nakatochi M; Kushima I; Ozaki N
    J Hum Genet; 2021 Jan; 66(1):25-37. PubMed ID: 32958875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advancing drug discovery for neuropsychiatric disorders using patient-specific stem cell models.
    Haggarty SJ; Silva MC; Cross A; Brandon NJ; Perlis RH
    Mol Cell Neurosci; 2016 Jun; 73():104-15. PubMed ID: 26826498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concise review: the promise of human induced pluripotent stem cell-based studies of schizophrenia.
    Brennand KJ; Gage FH
    Stem Cells; 2011 Dec; 29(12):1915-22. PubMed ID: 22009633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.